Connect with us
Potent statins are the best-proven weapon against heart disease, especially when paired with lifestyle changes. Most people aren’t active enough—and many are underdiagnosed—so starting treatment strong...
Fast walking, even just 15 minutes a day, can dramatically reduce the risk of death, especially from heart disease, according to a large study involving nearly...
What if we could predict obesity before it ever takes hold? A global team has created a genetic test that forecasts a child’s risk of adult...
A groundbreaking study involving genetic data from over five million people has uncovered how our DNA can predict obesity risk as early as childhood. The new...
People in richer countries aren’t moving less — they’re just eating more. A new Duke study shows that diet, not laziness, is fueling the obesity epidemic...
Erythritol, a widely used sugar substitute found in many low-carb and sugar-free products, may not be as harmless as once believed. New research from the University...
Semaglutide, a popular anti-obesity drug, may come with a hidden cost: significant muscle loss, especially in women and older adults. A small study found that up...
A new study comparing three popular diets—intermittent fasting, time-restricted eating, and continuous calorie cutting—found that all can help people with type 2 diabetes lose weight and...
A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant weight loss in obese mice but also slashed...
